265 (Mycophenolate mofetil 500 mg)

Pill imprint 265 has been identified as Mycophenolate mofetil 500 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; dermatomyositis; multiple sclerosis; autoimmune hepatitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 265

Mycophenolate mofetil 500 mg 265
Mycophenolate mofetil 500 mg 265
Mycophenolate mofetil
Imprint:
265
Strength:
500 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Ascend Laboratories LLC
National Drug Code (NDC):
67877-0225
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
povidone
microcrystalline cellulose
hypromelloses
polyethylene glycol
isopropyl alcohol
titanium dioxide
ferric oxide red
ferrosoferric oxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)